Current concepts and controversies in the treatment of parenchymal brain metastases: Improved outcomes with aggressive management

Cancer Investigation

Volumn 23, Issue 4, 2005, Pages 363-376

  Bajaj, Gopal K ^a   Kleinberg, Lawrence ^a   Terezakis, Stephanie ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Gamma knife; Radiotherapy; Stereotactic radiosurgery; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; EFAPROXIRAL; GADOLINIUM TEXAPHYRIN; RADIOSENSITIZING AGENT; TEMOZOLOMIDE; TENIPOSIDE;

BRAIN METASTASIS; BRAIN RADIATION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; FATIGUE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HEADACHE; HUMAN; INTERMETHOD COMPARISON; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIOSURGERY; REVIEW; STEREOTAXIC SURGERY; TREATMENT OUTCOME; VOMITING; BRAIN TUMOR; METASTASIS; MULTIMODALITY CANCER THERAPY; REPRODUCIBILITY;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM METASTASIS; RADIATION-SENSITIZING AGENTS; RADIOSURGERY; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 24744439741     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1081/CNV-58889     Document Type: Review

References (80)

1. Davey, P. Brain metastases: treatment options to improve outcomes. CNS Drugs 2002, 16 (5), 325-338.
2. Wen, P.Y.; Loeffler, J.S. Brain metastases. Curr. Treatm. Opt. Oncol. 2000, 1, 447-457.
3. Abrey, L.E.; Mehta, M.P. Treatment of brain metastases: a short review of current therapies and the emerging role of temozolomide. Clin. Adv. Hematol. Oncol. 2003, 1 (4), 231-236.
4. Gaspar, L.; Scott, C.; Rotman, M.; Asbell, S.; Phillips, T.; Wasserman, T.; McKenna, W.O.; Byhardt, R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37 (4), 745-751.
5. Markesbery, W.R.; Brooks, W.H.; Gupta, G.D.; Young, A.B.; et al. Treatment for patients with cerebral metastases. Arch. Neurol. 1978, 35 (11), 754-756.
6. Sundstrom, J.T.; Minn, H.; Lertola, K.K.; Nordman, E. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann. Med. 1998, 30 (3), 296-299.
7. Nieder, C.; Nestle, U.; Motaref, B.; Walter, K.; Niewald, M.; Schnabel, K. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int. J. Radiat. Oncol. Biol. Phys. 2000, 46 (2), 297-302.
8. Lentzsch, S.; Reichardt, P.; Weber, F.; Budach, V.; Dorken, B. Brain metastases in breast cancer: prognostic factors and management. Eur. J. Cancer 1999, 35 (4), 580-585.
9. Shaw, E.G. Radiotherapeutic management of multiple brain metastases: "3000 in 10" whole brain radiation is no longer a "no brainer." Int. J. Radiat. Oncol. Biol. Phys. 1999, 45 (2), 253-254.
10. Gaspar, L.E.; Scott, C.; Murray, K.; Curran, W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47 (4), 1001-1006.
11. Lutterbach, J.; Bartelt, S.; Ostertag, C. Long-term survival in patients with brain metastases. J. Cancer Res. Clin. Oncol. 2002, 128 (8), 417-425.
12. Borgelt, B.; Gelber, R.; Kramer, S.; Brady, L.W.; Chang, C.H.; Davis, L.W.; Perez, C.A.; Hendrickson, F.R. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 1980, 6 (1), 1-9.
13. Epstein, B.E.; Scott, C.B.; Sause, W.T.; Rotman, M.; Sneed, P.K.; Janjan, N.A.; Davis, L.W.; Selim, H.; Mohiuddin, M.; Wassermann, T.H.; et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28. Cancer 1993, 71 (4), 1362-1367.
14. Sause, W.T.; Scott, C.; Krisch, R.; Rotman, M.; Sneed, P.K.; Janjan, N.; Davis, L.; Curran, W.; Choi, K.N.; Selim, H.; et al. Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int. J. Radiat. Oncol. Biol. Phys. 1993, 26 (4), 653-657.
15. Murray, K.J.; Scott, C.; Greenberg, H.M.; Emami, B.; Seider, M.; Vora, N.L.; Olson, C.; Whitton, A.; Movsas, B.; Curran, W. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int. J. Radiat. Oncol. Biol. Phys. 1997, 39 (3), 571-574.
16. Agboola, O.; Benoit, B.; Cross, P.; Da Silva, V.; Esche, B.; Lesiuk, H.; Gonsalves, C. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42 (1), 155-159.
17. Auchter, R.M.; Lamond, J.P.; Alexander E.; Buatti, J.M.; Chappell, R.; Friedman, W.A.; Kinsella, T.J.; Levin, A.B.; Noyes, W.R.; Schultz, C.J.; Loefflcr, J.S.; Mehta, M.P. A multiinstitutional outcome and prognostic factor analysis of radiosurgcry for resectable single brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 1996, 35 (1), 27-35.
18. Yardeni, D.; Reichenthal, E.; Zucker, G.; Rubeinstein, A.; Cohen, M.; Israeli, V.; Shalit, M.N. Neurosurgical management of single brain metastasis. Surg. Neurol. 1984, 21 (4), 377-384.
19. Skibber, J.M.; Soong, S.J.; Austin, L.; Balch, C.M.; Sawaya, R.E. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann. Surg. Oncol. 1996, 3 (2), 118-123.
20. Smalley, S.R.; Schray, M.F.; Laws, E.R., Jr.; O'Fallon, J.R. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: association with pattern of failure and survival. Int. J. Radiat. Oncol. Biol. Phys. 1987, 13 (11), 1611-1616.
21. Dosoretz, D.E.; Blitzer, P.M.; Russell, A.H.; Wang, C.C. Management of solitary metastasis to the brain: the role of elective brain irradiation following complete surgical resection. Int. J. Radiat. Oncol. Biol. Phys. 1980, 6 (12), 1727-1730.
22. Patchell, R.A.; Tibbs, P.A.; Walsh, J.W.; Dempsey, R.J.; Maruyama, Y.; Kryscio, R.J.; Markesbery, W.R.; Macdonald, J.S.; Young, B. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 1990, 322 (8), 494-500.
23. Noordijk, E.M.; Vecht, C.J.; Haaxma-Reiche, H.; Padberg, G.W.; Voormolen, J.H.; Hoekstra, F.H.; Tans, J.T.; Lambooij, N.; Metsaars, J.A.; Watterndorff, A.R.; et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int. J. Radiat. Oncol. Biol. Phys. 1994, 29 (4), 711-717.
24. Mintz, A.M.; Kestle, J.; Rathbone, M.P.; Gaspar, L.; Hugenholtz, H.; Fisher, B.; Duncan, G.; Skingley, P.; Foster, G.; Levine, M. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78 (7), 1470-1476.
25. Vecht, C.J.; Haaxma-Reiche, H.; Noordijk, E.M.; Padberg, G.W.; Voormolen, J.H.; Hoekstra, F.H.; Tans, J.T.; Lambooij, N.; Metsaars, J.A.; Wattendorff, A.R.; et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann. Neurol. 1993, 33 (6), 583-590.
26. Mintz, A.P.; Cairncross, J.G. Treatment of a single brain metastasis: the role of radiation following surgical resection. JAMA 1998, 280 (17), 1527-1529.
27. Bindal, R.K.; Vecht, C.J.; Haaxma-Reiche, H.; Noordijk, E.M.; Padberg, G.W.; Voormolen, J.H.; Hoekstra, F.H.; Tans, J.T.; Lambooij, N.; Metsaars, J.A.; Wattendorff, A.R.; et al. Surgical treatment of multiple brain metastases. J. Neurosurg. 1993, 79 (2), 210-216.
28. Alexander, E., III; Moriarty, T.M.; Davis, R.B.; Wen, P.Y.; Fine, H.A.; Black, P.M.; Kooy, H.M.; Loeffler, J.S., III; et al. Stereotactic radiosurgery for the definitive, noninvasivc treatment of brain metastases. J. Natl. Cancer Inst. 1995, 87 (1), 34-40.
29. Flickinger, J.C.; Kondziolka, D.; Lunsford, L.D.; Coffey, R.J.; Goodman, M.L.; Shaw, E.G.; Hudgins, W.R.; Weiner, R.; Harsh, G.R., IV; Sneed, P.K.; et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 1994, 28 (4), 797-802.
30. Manning, M.A.; Cardinale, R.M.; Benedict, S.H.; Kavanagh, B.D.; Zwicker, R.D.; Amir, C.; Broaddus, W.C. Hypofractionated Stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47 (3), 603-608.
31. Petrovich, Z.; Yu, C.; Giannotta, S.L.; O'Day, S.; Apuzzo, M.L. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgcry. J. Neurosurg. 2002, 97 (Suppl. 5), 499-506.
32. Shirato, H.; Takamura, A.; Tomita, M.; Suzuki, K.; Nishioka, T.; Isu, T.; Kato, T.; Sawamura, Y.; Miyamachi, K.; Abe, H.; Miyasaka, K. Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37 (2), 385-391.
33. Schoeggl, A.; Kitz, K.; Ertl, A.; Reddy, M.; Bavinzski, G.; Schneider, B. Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients. J. Neuro-oncol. 1999, 42 (2), 169-175.
34. Vesagas, T.S.; Aguilar, J.A.; Mercado, E.R.; Mariano, M.M. Gamma knife radiosurgery and brain metastases: local control, survival, and quality of life. J. Neurosurg. 2002, 97 (Suppl. 5), 507-510.
35. Kondziolka, D.; Patel, A.; Lunsford, L.D.; Kassam, A.; Flickinger, J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 1999, 45 (2), 427-434.
36. Chougule, P.B.; Burton-Williams, M.; Saris, S.; Zheng, Z.; Ponte, B.; Noren, G.; Alderson, L.; Friehs, G.; Wazer, D.; Epstein, M. Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2000, 48, 114.
37. Sperduto, P.W.; Scott, C.; Andrews, D.; Schell, M.; Werner-Wasik, M.; Demas, W.; Ryu, J.K.; J. Fontanesi, J.; Rotman, M.; Curran, W. Preliminary report of RTOG 9508: a phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2000, 48, 113.
38. Sperduto, P.W.; Scott, C.; Andrews, D.; Schell, M.C.; Flanders, A.; Werner-Wasik, M.; Demas, W.; Ryu, J.K.; Gaspar, L.E.; Bahary, J.; et al. Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of radiation therapy oncology group phase III study 95-08 (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2002, 54, 3.
39. Sneed, P.K.; Lambom, K.R.; Forstner, J.M.; McDermott, M.W.; Chang, S.; Park, E.; Gutin, P.M.; Phillips, T.L.; Wara, W.M.; Larson, D.A. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int. J. Radiat. Oncol. Biol. Phys. 1999, 43 (3), 549-558.
40. Pirzkall, A.; Debus, J.; Lohr, F.; Fuss, M.; Rhein, B.; Engenhart-Cabillic, R.; Wannenmacher, M. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J. Clin. Oncol. 1998, 16 (11), 3563-3569.
41. Sneed, P.K.; Suh, J.H.; Goetsch, S.J.; Sanghavi, S.N.; Chappell, R.; Buatti, J.M.; Regine, W.F.; Weltman, E.; King, V.J.; Breneman, J.C.; Sperduto, P.W.; Mehta, M.P. A multi-institutional review of radio-surgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 2002. 53 (3), 519-526.
42. Varlotto, J.M.; Flickinger, J.C.; Niranjan, A.; Bhatnagar, A.K.; Kondziolka, D.; Lunsford, D. The impact of whole brain radiation therapy on the long-term control and morbidity of patients treated with gamma knife radiosurgery for brain metastases (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2003, 57 (Suppl. 2), S327.
43. Robinson, C.; Stephans, K.; Fu, P.; Pillai, K.; Maciunas, R.; Einstein, D.B. Impact of initial whole brain radiotherapy (WBRT) in addition to gamma knife radiosurgery (GKSRS) on the neurologic status of patients with newly diagnosed brain metastases (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2003, 57 (Suppl. 2), S326.
44. Regine, W.F.; Huhn, J.L.; Patchell, R.A.; St Clair, W.H.; Strottmann, J.; Meigooni, A.; Sanders, M.; Young, A.B. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgcry alone in patients with newly diagnosed brain metastases: results and implications. Int. J. Radiat. Oncol. Biol. Phys. 2002, 52 (2), 333-338.
45. Yan, E.S.; Snccd, P.K.; McDermott, M.W.; Kunwar, S.; Wara, W.M.; Larson, D.A. Number of brain metastases is not an important prognostic factor for survival following radiosurgery for newly-diagnosed non-melanoma brain metastases (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2003, 57 (Suppl. 2), S131.
46. Amendola, B.E.; Wolf, A.; Coy, S.; Amendola, M.A. Radiosurgery as palliation for brain metastases: a retrospective review of 72 patients harboring multiple lesions at presentation. J. Neurosurg. 2002, 97 (Suppl. 5), 511-514.
47. Yang, C.C.; Ting, J.; Wu, X.; Markoe, A. Dose volume histogram analysis of the gamma knife radiosurgery treating twenty-five metastatic intracranial tumors. Stereotact. Funct. Neurosurg. 1998, 70, 41-49.
48. Serizawa, T.; Iuchi, T.; Ono, J.; Saeki, N.; Osato, K.; Odaki, M.; Ushikubo, O.; Hirai, S.; Sato, M.; Matsuda, S. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy. J. Neurosurg. 2000, 93 (Suppl. 3), 32-36.
49. Bindal, R.K.; Sawaya, R.; Leavens, M.E.; Hess, K.R.; Taylor, S.H. Reoperation for recurrent metastatic brain tumors. J. Neurosurg. 1995, 83 (4), 600-604.
50. Johnson, J.D.; Young, B. Demographics of brain metastasis. Neurosurg. Clin. N. Am. 1996, 7 (3), 337-344.
51. Shaw, E.; Scott, C.; Souhami, L.; Dinapoli, R.; Kline, R.; Loeffler, J.; Farnan, N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47 (2), 291-298.
52. Wong, W.W.; Schild, S.E.; Sawyer, T.E.; Shaw, E.G. Analysis of outcome in patients reirradiated for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 1996, 34 (3), 585-590.
53. Cooper, J.S.; Steinfeld, A.D.; Lerch, I.A. Cerebral metastases: value of reirradiation in selected patients. Radiology 1990, 174 (3 Pt. 1), 883-885.
54. Hazuka, M.B.; Kinzie, J.J. Brain metastases: results and effects of re-irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1988, 15 (2), 433-437.
55. Kurup, P.; Reddy, S.; Hendrickson, F.R. Results of re-irradiation for cerebral metastases. Cancer 1980, 46 (12), 2587-2589.
56. Fenner, M.H.; Possinger, K. Chemotherapy for breast cancer brain metastases. Onkologie 2002, 25 (5), 474-479.
57. Kristensen, C.A.; Kristjansen, P.E.; Hansen, H.H. Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J. Clin. Oncol. 1992, 10 (9), 1498-1502.
58. Korfel, A.; Oehm, C.; von Pawel, J.; Keppler, U.; Deppermann, M.; Kaubitsch, S.; Thiel, E. Response to Topotecan of symptomatic brain metastases of small cell lung cancer after whole brain irradiation. A multicentre phase II study. Eur. J. Cancer 2002, 38, 1724.
59. Postmus, P.E.; Haaxma-Reiche, H.; Smit, E.F.; Groen, H.J.; Kamicka, H.; Lewinski, T.; van Meerbccck, J.; Clerico, M.; Gregor, A.; Curran, D.; Sahmoud, T.; Kirkpatrick, A.; Giaccone, G. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and tenipo-side with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J. Clin. Oncol. 2000, 18 (19), 3400-3408.
60. Franciosi, V.; Cocconi, G.; Michiara, M.; Di Costanzo, P.; Fosser, V.; Tonato, M.; Carlini, P.; Boni, C.; Di Sarra, S. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 1999, 85 (7), 1599-1605.
61. Rosner, D.; Nemoto, T.; Lane, W.W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986, 58 (4), 832-839.
62. Boogerd, W.; Dalesio, O.; Bais, E.M.; van der Sande, J.J. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 1992, 69 (4), 972-980.
63. Kaba, S.E.; Kyritsis, A.P.; Hess, K.; Yung, W.K.; Mercier, R.; Dakhil, S.; Jacckle, K.A.; Levin, V.A. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors. J. Clin. Oncol. 1997, 15 (3), 1063-1070.
64. Fleming, D.R.; Goldsmith, G.C.; Stevens, D.A.; Herzig, R.H. Dose-intensive chemotherapy for breast cancer with brain metastases: a case scries. Am. J. Clin. Oncol. 1999, 22 (4), 371-374.
65. Abrey, L.E.; Christodoulou, C. Temozolomide for treating brain metastases. Semin. Oncol. 2001, 28 (4 Suppl. 13), 34-42.
66. Christodoulou, C.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Bamias, A.; Papakostas, P.; Karabelis, A.; Bacoyiannis, C.; Skarlos, D.V.; Hellenic Cooperative Oncology Group. Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann. Oncol. 2001, 12 (2), 249-254.
67. Bafaloukos, D.; Gogas, H.; Georgoulias, V.; Briassoulis, E.; Fountzilas, G.; Samantas, E.; Kalofonos, Ch.; Skarlos, D.; Karabelis, A.; Kosmidis, P. Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group. J. Clin. Oncol. 2002, 20, 420-425.
68. Antonadou, D.; Paraskevaidis, M.; Sarris, G.; Coliarakis, N.; Economou, I.; Karagcorgis, P.; Throuvalas, N. Phase II randomized trial of tcmozolomidc and concurrent radiotherapy in patients with brain metastases. J. Clin. Oncol. 2002, 20 (17), 3644-3650.
69. Dardoufas, C.; Miliadou, A.; Skarleas, C.; Kouloulias, V.; Mavroidi, P.; Couvaris, J.; Gennatas, K.; Vassilaki, M.; Gogas, H.; Polyzos, A.; Couvoussis, E.; Vlachos, L. Concomitant temozolomide and radiotherapy followed by adjuvant treatment with temozolomide in patients with brain metastases from solid tumors (abstract). Proc. Am. Soc. Clin. Oncol. 2001, 20, 75b.
70. Verger, E.; Gil, M.; Yaya, R.; Vinolas, N.; Villa, S.; Pujol, T.; Solano, M.V.; Graus, F. Concomitant temozolomide and radiotherapy in patients with brain metastases: randomized multicentric phase II study, a preliminary report (abstract). Proc. Am. Soc. Clin. Oncol. 2002, 21, 78a.
71. Abrey, L.E.; Olson, J.D.; Raizer, J.J.; Mack, M.; Rodavitch, A.; Boutros, D.Y.; Malkin, M.G. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J. Neuro-oncol. 2001, 53 (3), 259-265.
72. van Rijn, J.; Heimans, J.J.; van den Berg, J.; van der Valk, P.; Slotman, B.J. Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47 (3), 779-784.
73. Antonadou, D.; Coliarakis, N.; Paraskevaidis, M.; Athanasiou, H.; Sarris, G.; Synodinou, M.; Skarlatos, I.; Sagriotis, A.; Georgakopoulos, G.; Beroukas, C.; et al. Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. A phase III study (abstract). Int. J. Radiat. Oncol. Biol. Phys. 2002, 54, 93.
74. Carde, P.; Timmerman, R.; Mehta, M.P.; Koprowski, C.D.; Ford, J.; Tishler, R.B.; Miles, D.; Miller, R.A.; Renschler, M.F. Multicenter phase Ib/II trial of the radiation enhancer Motexafin Gadolinium in patients with brain metastases. J. Clin. Oncol. 2001, 19, 2074-2083.
75. Mehta, M.P.; Rodrigus, P.; Terhaard, C.H.; Rao, A.; Suh, J.; Roa, W.; Souhami, L.; Bezjak, A.; Leibenhaur, M.; Komaki, R.; Schultz, C.; Timmerman, R.; Curran, W.; Smith, J.; Phan, S.C.; Miller, R.A.; Renschler, M.F. Survival and neurologic outcomes in randomized trial of Motexafin Gadolinium and whole brain radiation therapy in brain metastasis. J. Clin. Oncol. 2003, 21, 2529-2536.
76. Kleinbcrg, L.; Grossman, S.A.; Piantadosi, S.; Pearlman, J.; Engelhard, H.; Lesser, G.; Ruffer, J.; Gerber, M. Phase I trial to determine the safety, pharmacodynamics, and pharmacokinctics of RSR13, a novel radio-enhancer, in newly diagnosed glioblastoma multiforme. J. Clin. Oncol. 1999, 17 (8), 2593-2603.
77. Kleinbcrg, L.; Grossman, S.A.; Carson, K.; Lesser, G.; O'Neill, A.; Pearlman, J.; Phillips, P.; Herman, T.; Gerber, M. Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study. J. Clin. Oncol. 2002, 20 (14), 3149-3155.
78. Hall, E.J. Radiobiology for the radiobiologist. In Radiobiology for the Radiobiologist; Lippincott Williams & Wilkins: Philadelphia, 2000; 446-460.
79. Shaw, E.; Scott, C.; Suh, J.; Kadish, S.; Stea, B.; Hackman, J.; Pearlman, A.; Murray, K.; Gaspar, L.; Mehta, M.; Curran, W.; Gerber, M. RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. J. Clin. Oncol. 2003, 21 (12), 2364-2371.
80. Allos Therapeutics Submits First Component of Rolling New Drug Application for RSR13 for the Treatment of Brain Metastases from Breast Cancer; Allos Therapeutics, 2003. (http://www.allos.com/index.cfm?p2= 37140182&category1=abou&category2=busi&category3= x&catcgory5=x&catcgory6=x) April 24, 2005. 377-378